The Role of BiodentineTM on the Odontogenic/Osteogenic Differentiation of Human Dental Pulp Stem Cells

• Published in: Applied sciences Vol. 11; no. 16; p. 7563
• Main Authors: Abuarqoub, Duaa, Zaza, Rand, Aslam, Nazneen, Jafar, Hanan, Zalloum, Suzan, Atoom, Renata, Awidi, Abdalla
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 18.08.2021
• Subjects: Alizarin; Alkaline phosphatase; Biocompatibility; BiodentineTM; Biomedical engineering; Biomedical materials; Bone morphogenetic proteins; Calcium ions; Calcium signalling; Cell culture; Cell differentiation; Culture media; Dental materials; Dental pulp; dental stem cells; Dentin; Dentistry; differentiation; Differentiation (biology); DPSCs; Extracellular matrix; Flow cytometry; Gene expression; Genes; odontogenic; Osteocalcin; Osteogenesis; osteogenic; Osteopontin; Regenerative medicine; Signal transduction; Stem cells; Teeth; Tissue engineering; Tricalcium silicate; Variance analysis; United States > US
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/app11167563

The clinical use of bioactive material in the field of biomedical tissue engineering has become increasingly of interest in practice. This study investigates how BiodentineTM (BD), a tricalcium silicate cement, in culture media, affects the odonto/osteogenic differentiation potential of in vitro cultured human dental pulp stem cells (hDPSCs). hDPSCs were extracted and characterized for their expression profile by flow cytometry. Then, hDPSCs were cultured in media containing BD for 3 weeks to study the impact of BD on the odonto/osteogenesis pathway, compared to the positive control (osteogenic media) and negative control (cell culture media). Odonto/osteogenic differentiation of hDPSCs treated with BD was assessed by measuring the level of expression of odonto/osteogenic markers by flow cytometry, ELISA and Alizarin red stain. Additionally, the expression profile of the genes involved in the odonto/osteogenesis pathway was investigated, using PCR array. Our results indicate that hDPSCs treatment with BD results in an increased tendency for odonto/osteogenic differentiation. The BD treated group demonstrates a significant increase in the expression of odonto/osteogenic markers, osteocalcin (OCN) (p < 0.005), osteopontin (OPN) (p < 0.0005) and alkaline phosphatase (ALP) (p < 0.0005), and the presentation of calcium deposits by ARS, compared to the negative control by using t-test and ANOVA. Moreover, the BD-treated group is marked by the upregulation of genes related to the odonto/osteogenesis pathway, compared to the control groups, specifically the genes that are involved in the bone morphogenic protein (BMP) (p < 0.05) signaling pathway, the activation of the extracellular matrix-related gene (ECMG) (p < 0.05) and the Ca2+ signaling pathway (p < 0.05), compared to day 1 of treatment by using ANOVA. BD shows a stimulatory effect on the odonto/steogenic capacity of hDPSCs, suggesting BD as a good candidate and a very promising and useful means to be applied in regenerative medicine to regenerate dentine tissue in clinical settings.